However, since the comparisons for receptor agonists did not reach statistical significance, these SUCRA rankings should be interpreted with caution. 3.2.4.
← all excerpts
Efficacy and safety of pharmacological and biological therapies for amyotrophic lateral sclerosis: a network meta-analysis.
1
—
—